These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
939 related items for PubMed ID: 29028484
1. Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II. Gitt AK, Lautsch D, Ferrières J, De Ferrari GM, Vyas A, Baxter CA, Bash LD, Ashton V, Horack M, Almahmeed W, Chiang FT, Poh KK, Brudi P, Ambegaonkar B. Atherosclerosis; 2017 Nov; 266():158-166. PubMed ID: 29028484 [Abstract] [Full Text] [Related]
4. Frequency and predictors of cholesterol target attainment in patients with stable coronary heart disease in Belgium: results from the Dyslipidemia International Study II (DYSIS II CHD). Hermans MP, Gevaert S, Descamps O, Missault L, Gillot B, De Keyzer D, Lautsch D, Brudi P, Ambegaonkar B, Vyas A, Horack M, Gitt A. Acta Clin Belg; 2019 Dec; 74(6):399-404. PubMed ID: 30355016 [Abstract] [Full Text] [Related]
6. Low-density lipoprotein cholesterol target achievement in patients surviving an acute coronary syndrome in Hong Kong and Taiwan - findings from the Dyslipidemia International Study II. Yan BP, Chiang FT, Ambegaonkar B, Brudi P, Horack M, Lautsch D, Vyas A, Gitt AK. Int J Cardiol; 2018 Aug 15; 265():1-5. PubMed ID: 29885676 [Abstract] [Full Text] [Related]
7. Cholesterol goal achievement and lipid-lowering therapy in patients with stable or acute coronary heart disease in Singapore: results from the Dyslipidemia International Study II. Poh KK, Chin CT, Tong KL, Tan JKB, Lim JS, Yu W, Horack M, Vyas A, Lautsch D, Ambegaonkar B, Brudi P, Gitt AK. Singapore Med J; 2019 Sep 15; 60(9):454-462. PubMed ID: 30773600 [Abstract] [Full Text] [Related]
10. Risk Factors Associated with Failure to Achieve the Low Density Lipoprotein Cholesterol Therapeutic Target in Patients with Acute Coronary Syndrome: A Longitudinal, Single Centre Investigation. Hajahmadi Pourrafsanjani M, Khayati Shal E, Khezrpour S. High Blood Press Cardiovasc Prev; 2019 Feb 15; 26(1):37-43. PubMed ID: 30684247 [Abstract] [Full Text] [Related]
13. Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany. März W, Dippel FW, Theobald K, Gorcyca K, Iorga ŞR, Ansell D. Atherosclerosis; 2018 Jan 15; 268():99-107. PubMed ID: 29197254 [Abstract] [Full Text] [Related]
15. Lipid goal attainment in diabetes mellitus patients after acute coronary syndrome: a subanalysis of Dyslipidemia International Study II-China. Guo T, Chu C, Wang Y, He M, Jia H, Sun Y, Wang D, Liu Y, Huo Y, Mu J. BMC Cardiovasc Disord; 2023 Jul 01; 23(1):337. PubMed ID: 37393236 [Abstract] [Full Text] [Related]
16. Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome: a Danish population-based cohort study. Kristensen MS, Green A, Nybo M, Hede SM, Mikkelsen KH, Gislason G, Larsen ML, Ersbøll AK. BMC Cardiovasc Disord; 2020 Jul 13; 20(1):336. PubMed ID: 32660429 [Abstract] [Full Text] [Related]